Oral mucositis developed in 71.9% of patients undergoing allogeneic hematopoietic stem cell transplantation that compared four different pretransplant conditioning regimens.
A retrospective analysis of 185 patients evaluated OM incidence across the CY/TBI, BU/CY, FLU/BU, and FLU/MEL regimens. Both the conditioning regimen and the underlying disease emerged as independent factors associated with OM severity, with P values of .038 and .031.
High incidence rates appeared in both the FLU/BU group at 78.4% and the FLU/MEL group at 80%. Within the FLU/MEL cohort specifically, 40% of patients experienced severe grade 3 oral mucositis.
For the entire patient cohort, the D-index showed no association with OM severity. Within the FLU/BU regimen subgroup, researchers found that a day 7 D-index of 1310 or higher had an independent association with Grade 2 or greater oral mucositis, yielding an odds ratio of 3.82 and a P value of .003.
A day 10 D-index measurement of 2258 or higher in the same subgroup showed a similar association, with an odds ratio of 4.07 and a P value of .003. Discrimination stayed limited, showing an area under the curve of 0.639 for day 7 and 0.633 for day 10.
The Journal of Oral Biosciences published an exploratory prospective study that examined longitudinal dynamics of the oral and gut microbiota among 16 adult patients undergoing allogeneic hematopoietic stem cell transplantation at Kagawa University Hospital. All 16 patients developed oral mucositis during transplantation, comprising nine cases of grade 3, four cases of grade 2, and three cases of grade 1.
Bloodstream infections occurred in six of these patients, totaling 11 separate episodes with a median onset on post-transplantation day 8. Staphylococcus species represented the most frequent isolates in blood cultures, with hemolytic staphylococcus accounting for seven of the 11 episodes, followed by Enterococcus faecalis in two episodes.
Piperacillin/tazobactam and levofloxacin were the antibiotics most frequently used before the first bloodstream infection onset. Cumulative antibiotic exposure showed no difference between the BSI group and the non-BSI group.